- Adults due for preventive screening
- People with family history, prior abnormal results, smoking history or inherited risk
- People who need help reconciling sex, organs present, age and prior screening
Standard of care
TEST PASSPORT · REVIEWED JULY 2026
Guideline-based cancer screening
Build the schedule from age, anatomy, history and risk—then keep it current.Established screening includes different tests for colorectal, breast, cervical and lung cancer and other risk-based pathways. No single age or bundle fits everyone.
ACCESSClinic / performance labVaries by organ and risk
TURNAROUNDVariesProvider and location dependent
RELATIVE COST$–$$$$Total downstream cost matters
COMMERCE STATUSFacility pathwayPersonalized navigator + local qualified facility booking
HOW TO USE THIS PAGE
Decide whether this test deserves a place in your plan.
- 01Confirm the question
Be clear about what decision the result would change before ordering.
- 02Check fit and preparation
Review who it helps, who should pause and how to protect the quality of the signal.
- 03Plan the response
Know what you will do with a normal, abnormal or unclear result.
01 / WHO SHOULD TAKE IT
Fit the test to
the person.
Testing is useful when the result can change a real decision. These are educational selection criteria, not a diagnosis or personal order.- Anyone with a concerning symptom—symptom evaluation is diagnostic, not screening
- Replacing proven screening with a single blood test or whole-body scan
02 / SIGNAL VS. STORY
What it tells you.
What it cannot.
01
Which evidence-backed screening conversations are due
02
The tradeoffs among available methods
03
Where higher-risk pathways differ from average risk
01
Guidelines change
02
Screening can produce false positives, false negatives and overdiagnosis
03
Eligibility depends on details a generic checklist can miss
03 / MARKERS + RANGES
Read the panel
without chasing flags.
The report should show its own method, units and laboratory reference interval. Clinical decision thresholds may be different from a lab interval. We do not invent a universal “optimal” range where authoritative guidance does not support one.Use the laboratory unit and method, then interpret with symptoms, trend and the decision this marker can change.
Use the laboratory unit and method, then interpret with symptoms, trend and the decision this marker can change.
Use the laboratory unit and method, then interpret with symptoms, trend and the decision this marker can change.
Use the laboratory unit and method, then interpret with symptoms, trend and the decision this marker can change.
Use the laboratory unit and method, then interpret with symptoms, trend and the decision this marker can change.
Use the laboratory unit and method, then interpret with symptoms, trend and the decision this marker can change.
MEN, WOMEN + LIFE-STAGE CONTEXT
The correct range is personal context—not pink versus blue numbers.
Where biology differs, we call it out. Clinical interpretation should also reflect organs present, hormone therapy, pregnancy, age, medications and health history.
Breast, cervical, ovarian/uterine history, pregnancy and menopause can shape the plan; anatomy and prior surgery matter.
Prostate screening is preference- and risk-sensitive; breast and hereditary cancer risk still exist.
04 / PREPARATION
Protect the quality
of the signal.
The best assay cannot rescue the wrong timing, wrong specimen or wrong question. Follow the ordering clinician and laboratory instructions when they differ from this general guide.Collect prior reports, pathology, family diagnoses/ages, smoking exposure and surgeries.
Screen based on organs present and personal risk, not gender label alone.
Compare benefit, burden, interval and follow-up before choosing a modality.
REPEAT CADENCEUse the latest authoritative guideline for the exact modality and risk profile; store completion dates and next due dates.
05 / AFTER THE RESULT
Turn the number
into a next step.
- 01
Complete the highest-value overdue screen first
- 02
Route abnormal results promptly
- 03
Recalculate after family-history or health changes
DO NOT WAIT ON A CONSUMER TEST
New lump, bleeding, persistent change in bowel habits, unexplained weight loss or other concerning symptom needs diagnostic evaluation
06 / MODERN BIO SELECT
Built for a responsible purchase path.
The future product is a continuously updated screening wallet—not a maximal test bundle.Guideline-based cancer screening
- Future format
- Personalized navigator + local qualified facility booking
- Price position
- Screen-specific; insurance eligibility shown
- Before checkout
- Eligibility · method · privacy · total cost · interpretation · abnormal-result routing
07 / SCIENTIFIC FOUNDATION